NCT04015375 - Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris | Biotech Hunter

Enrollment

1,150

Participants

Timeline

Start Date

July 11, 2019

Primary Completion Date

February 3, 2020

Study Completion Date

February 22, 2020

Conditions

Acne Vulgaris

Interventions

DRUG

Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd)

Topical gel

DRUG

ACZONE® (dapsone) gel, 7.5% (Allergan, INC.)

Topical gel

OTHER

Placebo for Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd)

Topical gel

Trial Locations (13)

PEAK Research, LLC, Upper Saint Clair

Dermatology Consulting Services, PLLC, High Point

FXM Clinical Research Miramar, Miramar

FXM Clinical Research Miami, Miami

MOORE Clinical Research, Inc., Brandon

MOORE Clinical Research, Inc. (S. Tampa Site), Tampa

MOORE Clinical Research, Inc. (Temple Terrace Site), Temple Terrace

Research Institute of Central Florida, Winter Park

3A Research, LLC - WEST, El Paso

3A Research, LLC - EAST, El Paso

Unison Center for Clinical Trials, Sherman Oaks

Dermatology & Skin Surgery Centre/ FXM Research International, Belize City

Dr. Moguel's Clinic/ FXM Research International, Belize City